| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10911210 | Lung Cancer | 2014 | 7 Pages | 
Abstract
												Our findings argue for an enrichment of FGFR1 amplifications in brain metastases of adenocarcinomas (where they were 5-fold more frequent than reported for primary tumors) and possibly also of other non-squamous carcinomas, but not in squamous cell carcinomas of the lung. These results may be relevant for targeted therapy and prophylaxis of NSCLC brain metastases.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Matthias Preusser, Anna S. Berghoff, Walter Berger, Aysegül Ilhan-Mutlu, Carina Dinhof, Georg Widhalm, Karin Dieckmann, Adelheid Wöhrer, Monika Hackl, Andreas von Deimling, Berthold Streubel, Peter Birner, 
											